Valuation: Jamjoom Pharmaceuticals Factory Company

Market Cap 10.29B 2.74B 2.4B 2.22B 2.04B 3.85B 264B 3.91B 26.55B 10.41B 129B 10.07B 445B P/E 2026 *
19.8x
P/E 2027 * -
Enterprise Value 9.97B 2.66B 2.33B 2.15B 1.98B 3.73B 256B 3.79B 25.73B 10.09B 125B 9.76B 432B EV / Sales 2026 *
6.17x
EV / Sales 2027 * 5.28x
Free-Float
38.61%
Yield 2026 *
3.05%
Yield 2027 * 3.39%

Last Transcript: Jamjoom Pharmaceuticals Factory Company

1 day+1.87%
1 week-0.54%
Current month-5.16%
1 month-10.15%
3 months-5.22%
6 months+3.59%
Current year+3.30%
1 week 144
Extreme 144
148.9
1 month 144
Extreme 144
163.3
Current year 125
Extreme 125
163.7
1 year 125
Extreme 125
179.3
3 years 100.2
Extreme 100.2
202.4
5 years 66
Extreme 66
202.4
10 years 66
Extreme 66
202.4
Manager TitleAgeSince
Chief Executive Officer 62 2021-05-14
Director of Finance/CFO 62 2013-01-12
Chief Operating Officer 31 2021-08-31
Director TitleAgeSince
Director/Board Member - 2022-06-18
Chairman 66 2022-06-18
Director/Board Member 41 2022-06-18
Change 5-day change 1-year change 3-year change Capi.($)
+1.87%-0.54%-16.67%+18.17% 2.69B
+1.23%+1.08%+15.52%+80.84% 48.15B
-0.23%-1.65%+67.15%+109.36% 35.59B
+1.61%+0.15%-2.75%+39.18% 11.9B
+0.46%-0.16%+17.85%+89.14% 11.85B
+1.21%+2.49%+34.42%+136.73% 9.31B
+3.37%-0.10%+51.64%-4.77% 7.02B
-0.42%-1.32%+16.96%+35.57% 6.91B
-.--%+0.14% - - 6.79B
+0.18%-1.90%+0.63%+211.00% 6.55B
Average +0.93%-0.82%+20.53%+79.47% 14.68B
Weighted average by Cap. +0.78%-0.73%+29.12%+87.33%

Financials

2026 *2027 *
Net sales 1.62B 431M 377M 349M 321M 605M 41.53B 615M 4.17B 1.64B 20.32B 1.58B 70B 1.87B 498M 437M 404M 371M 701M 48.05B 712M 4.83B 1.89B 23.51B 1.83B 81B
Net income 521M 139M 122M 112M 103M 195M 13.38B 198M 1.34B 527M 6.55B 510M 22.55B -
Net Debt -317M -84.42M -73.99M -68.4M -62.91M -119M -8.14B -121M -818M -321M -3.98B -310M -13.72B -404M -108M -94.3M -87.17M -80.17M -151M -10.37B -154M -1.04B -409M -5.08B -395M -17.49B
Logo Jamjoom Pharmaceuticals Factory Company
Jamjoom Pharmaceuticals Factory Company SJSC is a Saudi Arabia-based pharmaceutical company, which is primarily focused on developing, manufacturing, and distributing generic pharmaceuticals, cosmetics, and consumer healthcare products. It produces human medicines, nutraceuticals, antibiotics, general analgesics, medicines for treatment of cough, allergy, asthma, heart diseases, blood pressure, diarrhoea, vomiting, and ulcer and acidity, among others. It operates in two segments: The Pharmaceutical products that represents medicines or drugs for the prevention and treatment of diseases, and protection of public health; and The Consumer health products that represents products used to support personal well-being, maintain health, or address specific health-related needs. The Company’s subsidiaries include Al Jamjoom Pharma for Pharmaceutical Industries and Jamjoom Pharmaceutical Industry and Commerce Company Limited and the Company also operates approximately 8 branches.
Employees
-
Date Price Change Volume
26-07-20 SAR 147.00 +1.87% 9,370
26-07-19 SAR 144.30 -1.77% 17,452
26-07-16 SAR 146.90 -1.34% 18,428
26-07-15 SAR 148.90 +2.69% 46,390
26-07-14 SAR 145.00 -1.09% 13,093
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
147.00SAR
Average target price
164.24SAR
Spread / Average Target
+11.73%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4015 Stock